Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
Puma Biotechnology Inc (NASDAQ: PBYI) closed the day trading at $2.95 down -5.45% from the previous closing price of $3.12. In other words, the price has decreased by -$5.45 from its previous closing price. On the day, 0.84 million shares were traded. PBYI stock price reached its highest trading level at $3.185 during the session, while it also had its lowest trading level at $2.92.
Ratios:
For a better understanding of PBYI, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.42 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.07. For the most recent quarter (mrq), Quick Ratio is recorded 1.40 and its Current Ratio is at 1.42. In the meantime, Its Debt-to-Equity ratio is 1.21 whereas as Long-Term Debt/Eq ratio is at 0.50.
Goldman Downgraded its Neutral to Sell on October 08, 2019, whereas the target price for the stock was revised from $24 to $8.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 02 ’25 when NOUGUES MAXIMO F sold 10,227 shares for $3.15 per share. The transaction valued at 32,232 led to the insider holds 152,295 shares of the business.
Ludwig Jeffrey Jerome sold 9,437 shares of PBYI for $29,743 on Jan 02 ’25. The Chief Commercial Officer now owns 108,951 shares after completing the transaction at $3.15 per share. On Jan 02 ’25, another insider, HUNT DOUGLAS M, who serves as the insider of the company, sold 8,633 shares for $3.15 each. As a result, the insider received 27,209 and left with 124,594 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PBYI now has a Market Capitalization of 144808720 and an Enterprise Value of 134453664. As of this moment, Puma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 6.21, and their Forward P/E ratio for the next fiscal year is 8.68. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.56 while its Price-to-Book (P/B) ratio in mrq is 2.04. Its current Enterprise Value per Revenue stands at 0.552 whereas that against EBITDA is 3.015.
Stock Price History:
Over the past 52 weeks, PBYI has reached a high of $7.73, while it has fallen to a 52-week low of $2.22. The 50-Day Moving Average of the stock is -0.75%, while the 200-Day Moving Average is calculated to be -15.72%.
Shares Statistics:
Over the past 3-months, PBYI traded about 446.03K shares per day on average, while over the past 10 days, PBYI traded about 651180 shares per day. A total of 49.07M shares are outstanding, with a floating share count of 34.86M. Insiders hold about 28.99% of the company’s shares, while institutions hold 54.36% stake in the company. Shares short for PBYI as of 1734048000 were 2906650 with a Short Ratio of 6.52, compared to 1731628800 on 2983953. Therefore, it implies a Short% of Shares Outstanding of 2906650 and a Short% of Float of 6.98.
